cardiomyopathy
Later this year, the inherited cardiovascular disease clinic also plans to implement a preventive genomics program with polygenic risk score and PGx testing.
Cascade Testing for Dilated Cardiomyopathy Likely to Be Cost Effective, Analysis Finds
An Australian team developed a decision model for testing asymptomatic relatives of patients with dilated cardiomyopathy to assess the cost effectiveness of testing.
Johns Hopkins, Mayo Researchers Publish Guide to Phase Out Heart Attack Test
The scientists argued that studies indicate the creatine kinase-myocardial band testing has no "incremental value to patient care" and outlined steps to put the test to rest.